menu
    • menu

    Company profile for HekaBio

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HekaBio is an emerging commercial-stage biopharma and MedTech platform focused on in-licensing early, de-risked assets for Japan and the APAC region. We drive value by conducting clinical trials, securing regulatory and pricing approvals, and maximizing commercialization through our strong network of pharma, MedTech, hospitals, and government partners. With 50+ approvals in Japan and a diverse portfolio, our multicultural team...
    HekaBio is an emerging commercial-stage biopharma and MedTech platform focused on in-licensing early, de-risked assets for Japan and the APAC region. We drive value by conducting clinical trials, securing regulatory and pricing approvals, and maximizing commercialization through our strong network of pharma, MedTech, hospitals, and government partners. With 50+ approvals in Japan and a diverse portfolio, our multicultural team is poised for commercial sales from Q1 2026.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HekaBiojapan Flag
    Country
    Country
    Japan
    Address
    Address
    Chikiriya Tokyo Bldg. 8F 1-9-15 Nihonbashimuromachi Chuo-ku, Tokyo 103-0022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.heka.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KIFFIK Biomedical, HekaBio Form ISF Alliance in Asia-Pacific
    KIFFIK Biomedical, HekaBio Form ISF Alliance in Asia-Pacific

    24 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-24/kiffik-biomedical-and-hekabio-announce-strategic-alliance-to-expand-isf-based-molecular-access-acros

    PHARMIWEB
    24 Mar 2026
    Share Share
    HekaBio Partners with Alfresa Holdings Corporation
    HekaBio Partners with Alfresa Holdings Corporation

    16 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250615766110/en/HekaBio-Japan-based-Biopharma-and-MedTech-Platform-Enters-Strategic-Partnership-with-Alfresa-Holdings-Corporation

    BUSINESSWIRE
    16 Jun 2025
    Share Share
    Limaca Medical and HekaBio announce partnership
    Limaca Medical and HekaBio announce partnership

    17 May 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/27/20307/limaca-medical-and-hekabio-announce-partnership.html

    BIOSPECTRUMASIA
    17 May 2022
    Share Share
    Orgenesis announces license agreement with HekaBio in Japan
    Orgenesis announces license agreement with HekaBio in Japan

    05 Oct 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/26/11825/orgenesis-announces-license-agreement-with-hekabio-in-japan.html

    BIOSPECTRUM
    05 Oct 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search